Affinity Asset Advisors, LLC — 13F holdings

Affinity Asset Advisors, LLC reported 113 holdings worth $2.21B in its 13F filing for Q2 2026, filed August 13, 2026.

Largest positions

1. ROIV Roivant Sciences Ltd — $133M (6.0%)
2. APGE APOGEE THERAPEUTICS INC — $131M (5.9%)
3. SYRE SPYRE THERAPEUTICS INC — $114M (5.1%)
4. XENE XENON PHARMACEUTICALS INC — $96.3M (4.4%)
5. ERAS Erasca Inc — $96.2M (4.3%)
6. ALKS Alkermes PLC — $72.0M (3.3%)
7. INSM INSMED INC — $69.3M (3.1%)
8. MRNA Moderna Inc — $68.3M (3.1%)
9. PRAX PRAXIS PRECISION MEDICINES I — $61.9M (2.8%)
10. ORKA ORUKA THERAPEUTICS INC — $56.2M (2.5%)